심장 모니터링 및 심장 박동 관리 기기 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Summary

The global cardiac monitoring and cardiac rhythm management devices market size was estimated at USD 21.84 billion in 2024 and is projected to reach USD 32.34 billion by 2033, growing at a CAGR of 4.45% from 2025 to 2033. Increasing cardiovascular incidence is one of the key factors driving the market's growth.

According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease reaches about 7,179 cases per 100,000 people, emphasize the significant and ongoing impact of heart conditions globally. Such widespread prevalence means that millions are living with diseases that require careful monitoring and timely intervention to prevent complications. This fuels demand for cardiac monitoring and cardiac rhythm management devices, which are critical for identifying abnormal heart rhythms, managing chronic heart conditions, and reducing the risk of serious cardiac events.

Increasing awareness campaigns and government-initiated screening programs for early detection of CVDs contribute to market expansion by ensuring more patients receive timely diagnosis and treatment. According to an article published by Hearst Newspapers II, LLC in June 2025, Midland Memorial Hospital, working alongside the Championship Hearts Foundation, conducts free ECG and limited echocardiogram screenings for teenagers between 14 and 18 years old. In previous events, these screenings identified severe, potentially life-threatening heart conditions, such as hypertrophic cardiomyopathy, in approximately 1 out of every 250 participants. Initiatives like this highlight the critical role of early detection in preventing sudden cardiac events among young people. They also emphasize the growing need for portable ECG devices and advanced rhythm-monitoring technologies tailored for pediatric and adolescent populations, contributing to expanding the cardiac monitoring and cardiac rhythm management devices market.

Furthermore, according to the American Heart Association, Inc. article published in November 2023, the 2023 guidelines issued by the American Heart Association (AHA), American College of Cardiology (ACC), American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) emphasize the importance of increasing awareness and incorporating routine screening for atrial fibrillation (AFib), especially among high-risk groups like older adults. These recommendations advocate for regular pulse and ECG screenings to facilitate early diagnosis and effective treatment. Detecting and managing AFib promptly is vital because it can substantially reduce the risk of stroke and other serious health problems. This focus on proactive screening and education drives up demand for cardiac monitoring and rhythm management devices, which are essential for identifying heart rhythm disorders and guiding proper medical care, thereby boosting market growth.

The efficiency of targeted screening programs for CVDs fuels market growth. According to Springer Nature, in June 2024,a review of cardiology reports examines the impact of screening programs. It highlights findings from multicenter studies, such as AF-SCREEN and STROKESTOP, which show that targeted screening greatly enhances the detection of CVDs, especially among older adults. The review strongly supports establishing national screening initiatives to address the growing burden of AFib-related complications, highlighting the critical role of early detection and intervention.

The technologically advanced products offered by the key players drive the market's growth. For instance, in April 2025, LifeSignals, Inc. introduced the UbiqVue 2AYe Holter System at Heart Rhythm 2025. This new Holter monitoring solution, distributed in collaboration with UltraLinQ Healthcare Solutions, is designed to streamline cardiac monitoring workflows by producing diagnostic reports far faster than traditional methods and eliminating the need to mail or physically retrieve the biosensor device.

At the heart of the UbiqVue system is the 2AYe Biosensora, a disposable, chest-worn device capable of continuously recording two-channel ECG and event data for up to five days. Data collected by the biosensor is securely encrypted and sent via a patient-facing mobile app to a cloud-based platform during the monitoring period. Once the Holter test concludes, the patient's data is quickly analyzed through cloud-based ECG analytics, substantially reducing the review time required by certified cardiac technicians and enabling physicians to access finalized reports within hours.

Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each sub-segments from 2021 to 2033 at the global, regional, and country levels. For this report, Grand View Research has segmented the global cardiac monitoring and cardiac rhythm management devices market report based on product, end use, and region:

• Product Outlook (Revenue USD Million, 2021 - 2033)
• Cardiac Monitoring Devices
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
• Cardiac Rhythm Management Devices
  • Cardiac Resynchronization Therapy (CRT)
  • CRT-Defibrillator
  • CRT-Pacemakers
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICD)
  • Single Chamber
  • Dual Chamber
  • External Defibrillator
  • Manual External Defibrillator
  • Automatic External Defibrillator
  • Wearable Cardioverter Defibrillator
  • Pacemakers
  • Conventional
  • Leadless
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End Use outlook
• 2.3. Competitive Insights

Chapter 3. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising cardiovascular incidence
    • 3.2.1.2. Increasing awareness and screening programs for cardiac cases
    • 3.2.1.3. Technological advancements in cardiac monitoring & rhythm management devices
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost associated with devices
    • 3.2.2.2. Product recalls
• 3.3. Global Cardiac Monitoring And Cardiac Rhythm Management: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis

Chapter 4. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by Product, 2021 to 2033
• 4.5. Cardiac Monitoring Devices
  • 4.5.1. Cardiac monitoring devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. ECG
    • 4.5.2.1. ECG market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.3. Implantable cardiac monitors
    • 4.5.3.1. Implantable cardiac monitors market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.4. Holter Monitors
    • 4.5.4.1. Holter monitors market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.5. Mobile Cardiac Telemetry
    • 4.5.5.1. Mobile cardiac telemetry market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Cardiac Rhythm Management Devices
  • 4.6.1. Cardiac rhythm management devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. Cardiac Resynchronization Therapy (CRT)
    • 4.6.2.1. Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.2.1.1. CRT-Defibrillator
        • 4.6.2.1.1.1. CRT-Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.2.1.2. CRT-Pacemakers
        • 4.6.2.1.2.1. CRT-Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.3. Defibrillator
    • 4.6.3.1. Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.3.1.1. Implantable Cardioverter Defibrillators (ICD)
        • 4.6.3.1.1.1. Implantable Cardioverter Defibrillators (ICD) market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.1.2. Single Chamber
          • 4.6.3.1.1.2.1. Single Chamber market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.1.3. Dual Chamber
          • 4.6.3.1.1.3.1. Dual Chamber market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.3.1.2. External Defibrillator
        • 4.6.3.1.2.1. External Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.2.2. Manual External Defibrillator
          • 4.6.3.1.2.2.1. Manual External Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.2.3. Automatic External Defibrillator
          • 4.6.3.1.2.3.1. Automatic External Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.2.4. Wearable Cardioverter Defibrillator
          • 4.6.3.1.2.4.1. Wearable Cardioverter Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.4. Pacemakers
    • 4.6.4.1. Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.4.1.1. Conventional
        • 4.6.4.1.1.1. Conventional market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.4.1.2. Leadless
        • 4.6.4.1.2.1. Leadless market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by End Use, 2021 to 2033
• 5.5. Hospitals
  • 5.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
• 5.6. Ambulatory Surgery Centers
  • 5.6.1. Ambulatory surgery centers market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 6. Cardiac Monitoring And Cardiac Rhythm Management Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2034
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Cardiac Monitoring And Cardiac Rhythm Management Devices Market Share by Region, 2024 & 2033:
• 6.5. North America
  • 6.5.1. North America cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Scenario
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. U.S. cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Scenario
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Canada cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Scenario
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Mexico cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Scenario
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. UK cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Scenario
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Germany cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Scenario
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. France cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Scenario
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Italy cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Scenario
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Spain cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Scenario
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. Norway cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Regulatory Scenario
    • 6.6.8.3. Competitive Scenario
    • 6.6.8.4. Sweden cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Regulatory Scenario
    • 6.6.9.3. Competitive Scenario
    • 6.6.9.4. Denmark cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Scenario
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Japan cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Scenario
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. China cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Scenario
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. India cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Scenario
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Australia cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Regulatory Scenario
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. South Korea cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Regulatory Scenario
    • 6.7.6.3. Competitive Scenario
    • 6.7.6.4. Thailand cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Scenario
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. Brazil cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Scenario
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. Argentina cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key Country Dynamics
    • 6.9.1.2. Regulatory Scenario
    • 6.9.1.3. Competitive Scenario
    • 6.9.1.4. South Africa cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Scenario
    • 6.9.2.3. Competitive Scenario
    • 6.9.2.4. Saudi Arabia cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Scenario
    • 6.9.3.3. Competitive Scenario
    • 6.9.3.4. UAE cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Scenario
    • 6.9.4.3. Competitive Scenario
    • 6.9.4.4. Kuwait cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Profiles
  • 7.3.1. Stryker
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Medtronic
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Abbott
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Boston Scientific Corporation
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Koninklijke Philips N.V.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. ZOLL Medical Corporation. (Asahi Kasei company)
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. GE HealthCare
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. MicroPort Scientific Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. NIHON KOHDEN CORPORATION
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Biotronik SE & Co KG
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives